| CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis V Annibali, G Ristori, DF Angelini, B Serafini, R Mechelli, S Cannoni, ... Brain 134 (2), 542-554, 2011 | 251 | 2011 |
| Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple … SV Abrahamsson, DF Angelini, AN Dubinsky, E Morel, U Oh, JL Jones, ... Brain 136 (9), 2888-2903, 2013 | 215 | 2013 |
| Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients M Logozzi, DF Angelini, E Iessi, D Mizzoni, R Di Raimo, C Federici, ... Cancer letters 403, 318-329, 2017 | 211 | 2017 |
| FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways DF Angelini, G Borsellino, M Poupot, A Diamantini, R Poupot, G Bernardi, ... Blood 104 (6), 1801-1807, 2004 | 196 | 2004 |
| The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells R Busa, MP Paronetto, D Farini, E Pierantozzi, F Botti, DF Angelini, ... Oncogene 26 (30), 4372-4382, 2007 | 195 | 2007 |
| Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis DF Angelini, B Serafini, E Piras, M Severa, EM Coccia, B Rosicarelli, ... PLoS pathogens 9 (4), e1003220, 2013 | 179 | 2013 |
| Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult … F Buccisano, L Maurillo, A Spagnoli, MI Del Principe, D Fraboni, ... Blood, The Journal of the American Society of Hematology 116 (13), 2295-2303, 2010 | 177 | 2010 |
| Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes M Logozzi, D Mizzoni, DF Angelini, R Di Raimo, M Falchi, L Battistini, ... Cancers 10 (10), 370, 2018 | 169 | 2018 |
| Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9Vδ2 naive, memory and effector T cell subsets N Caccamo, S Meraviglia, V Ferlazzo, D Angelini, G Borsellino, F Poccia, ... European journal of immunology 35 (6), 1764-1772, 2005 | 153 | 2005 |
| Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study MC Buscarinu, B Cerasoli, V Annibali, C Policano, L Lionetto, M Capi, ... Multiple Sclerosis Journal 23 (3), 442-446, 2017 | 151 | 2017 |
| Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors E Iessi, M Logozzi, L Lugini, T Azzarito, C Federici, EP Spugnini, ... Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 648-657, 2017 | 108 | 2017 |
| Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response D Mattoscio, V Evangelista, R De Cristofaro, A Recchiuti, A Pandolfi, ... The FASEB Journal 24 (10), 3970-3980, 2010 | 93 | 2010 |
| TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types R Galli, D Starace, R Busa, DF Angelini, A Paone, P De Cesaris, ... The Journal of Immunology 184 (12), 6658-6669, 2010 | 91 | 2010 |
| Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells A Ferri, M Nencini, A Casciati, M Cozzolino, DF Angelini, P Longone, ... The FASEB journal 18 (11), 1261-1263, 2004 | 84 | 2004 |
| Increased plasmatic levels of PSA-expressing exosomes distinguish prostate cancer patients from benign prostatic hyperplasia: a prospective study M Logozzi, DF Angelini, A Giuliani, D Mizzoni, R Di Raimo, M Maggi, ... Cancers 11 (10), 1449, 2019 | 79 | 2019 |
| A leukemia-associated CD34/CD123/CD25/CD99+ immunophenotype identifies FLT3-mutated clones in acute myeloid leukemia DF Angelini, T Ottone, G Guerrera, S Lavorgna, M Cittadini, F Buccisano, ... Clinical Cancer Research 21 (17), 3977-3985, 2015 | 76 | 2015 |
| BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib I Faraoni, M Compagnone, S Lavorgna, DF Angelini, MT Cencioni, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (3), 462-472, 2015 | 75 | 2015 |
| Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration A Maracchioni, A Totaro, DF Angelini, A Di Penta, G Bernardi, MT Carrì, ... Journal of neurochemistry 100 (1), 142-153, 2007 | 70 | 2007 |
| Epstein-Barr virus genetic variants are associated with multiple sclerosis R Mechelli, C Manzari, C Policano, A Annese, E Picardi, R Umeton, ... Neurology 84 (13), 1362-1368, 2015 | 69 | 2015 |
| Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. M Coscia, C Vitale, S Peola, M Foglietta, M Rigoni, V Griggio, B Castella, ... Blood, 2012 | 69 | 2012 |
